Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

Human papillomaviruses (HPVs), which belong to the <i>Papillomaviridae</i> family, constitute a group of small nonenveloped double-stranded DNA viruses. HPV has a small genome that only encodes a few proteins, and it is also responsible for 5% of all human cancers, including cervical, va...

Full description

Bibliographic Details
Main Authors:	Daria A. Haręża, Jacek R. Wilczyński, Edyta Paradowska
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	International Journal of Molecular Sciences
Subjects:	gynecological cancers human papillomavirus oncoprotein
Online Access:	https://www.mdpi.com/1422-0067/23/3/1818

Similar Items

Role of human papillomavirus in carcinogenesis
by: Vishwa Tilva, et al.
Published: (2024-01-01)

Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge
by: Ena Pešut, et al.
Published: (2021-11-01)

Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells
by: Juan P. Muñoz, et al.
Published: (2018-12-01)

The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs
by: Maria Vincenza Chiantore, et al.
Published: (2022-06-01)

In silico Structural Prediction of E6 and E7 Proteins of Human Papillomavirus Strains by Comparative Modeling
by: Satish Kumar, et al.
Published: (2012-07-01)

Structural Insights in Multifunctional Papillomavirus Oncoproteins
by: Irina Suarez, et al.
Published: (2018-01-01)

Virus–Host Protein–Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities
by: Guillem Dayer, et al.
Published: (2020-10-01)

The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer
by: Katarzyna D. Kania, et al.
Published: (2022-10-01)

Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review
by: Emad A. Elsamadicy, et al.
Published: (2019-08-01)

Human Papillomavirus 16 E7 Promotes EGFR/PI3K/AKT1/NRF2 Signaling Pathway Contributing to PIR/NF-κB Activation in Oral Cancer Cells
by: Diego Carrillo-Beltrán, et al.
Published: (2020-07-01)

Expediency of immunocytochemical study as a marker of proliferative activity in cervical intraepithelial neoplasia
by: Tatyana Yu. Pestrikova, et al.
Published: (2022-01-01)

New positions for peptide presentation in Potato virus X capsid protein
by: Vaculik Petr, et al.
Published: (2015-03-01)

The Protein Tyrosine Phosphatase H1 PTPH1 Supports Proliferation of Keratinocytes and is a Target of the Human Papillomavirus Type 8 E6 Oncogene
by: Stefanie Taute, et al.
Published: (2019-03-01)

Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms
by: Dariusz Jarych, et al.
Published: (2024-01-01)

Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
by: Chenhao Zhou, et al.
Published: (2019-08-01)

Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins
by: Irene Lo Cigno, et al.
Published: (2020-04-01)

Pathological Similarities in the Development of Papillomavirus-Associated Cancer in Humans, Dogs, and Cats
by: Alfredo Cruz-Gregorio, et al.
Published: (2022-09-01)

Papillomavirus E5: the smallest oncoprotein with many functions
by: Venuti Aldo, et al.
Published: (2011-11-01)

Women with Cervical High-Risk Human Papillomavirus: Be Aware of Your Anus! The ANGY Cross-Sectional Clinical Study
by: Martine Jacot-Guillarmod, et al.
Published: (2022-10-01)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
by: Asmita Pal, et al.
Published: (2020-01-01)

Enhanced Intracellular Photosensitizer Uptake and Retention by Targeting Viral Oncoproteins in Human Papillomavirus Infected Cancer Cells and Cancer Stem Cells
by: Elvin Peter Chizenga, et al.
Published: (2023-01-01)

Bovine Papillomavirus Type 2 Infection Associated with Papillomatosis of the Amniotic Membrane in Water Buffaloes (<i>Bubalus bubalis</i>)
by: Valeria Russo, et al.
Published: (2020-04-01)

Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia
by: Kirubel Eshetu Ali, et al.
Published: (2019-08-01)

Anal Cancer and Anal Intraepithelial Neoplasia Risk among Patients Treated for HPV-Related Gynecological Diseases—A Systematic Review
by: Michał Brzeziński, et al.
Published: (2023-06-01)

High Rate of Infection by Only Oncogenic Human Papillomavirus in Amerindians
by: Daniela Vargas-Robles, et al.
Published: (2018-06-01)

HPV-Induced Oropharyngeal Cancer and the Role of the E7 Oncoprotein Detection via Brush Test
by: Wegene Borena, et al.
Published: (2020-08-01)

Genomic Signatures in HPV-Associated Tumors
by: Suleman S. Hussain, et al.
Published: (2021-10-01)

HPV8-E6 Interferes with Syntenin-2 Expression through Deregulation of Differentiation, Methylation and Phosphatidylinositide-Kinase Dependent Mechanisms
by: Benjamin Marx, et al.
Published: (2017-09-01)

Bovine delta papillomavirus E5 oncoprotein negatively regulates the cGAS-STING signaling pathway in cattle in a spontaneous model of viral disease
by: Francesca De Falco, et al.
Published: (2022-10-01)

E7 oncoprotein as a marker for persistence of human papillomavirus infection in patients with chronic cervicitis
by: T Y Pestrikova, et al.
Published: (2014-06-01)

Molecular detection of oncogenic subtypes of human papillomavirus (HPV) in a group of women in the Amazon region of Brazil
by: Alessandra Silva e Silva, et al.
Published: (2020-02-01)

Mitochondrial DNA mutations in gynecological cancers
by: Kinga Księżakowska, et al.
Published: (2011-12-01)

Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression
by: Naoko Kajitani, et al.
Published: (2020-09-01)

The complexity of human papilloma virus in cancers: a narrative review
by: Vahideh Hamidi Sofiani, et al.
Published: (2023-02-01)

The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review
by: Ayazhan Akhatova, et al.
Published: (2021-12-01)

Key Molecular Events in Cervical Cancer Development
by: Shandra Devi Balasubramaniam, et al.
Published: (2019-07-01)

The gynecological sourcebook /
by: 369762 Rosenthal, M. Sara
Published: (2003)

Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent?
by: Rancés Blanco, et al.
Published: (2021-08-01)

Co‐administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model
by: Fariba Dorostkar, et al.
Published: (2021-01-01)

Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer
by: Parinaz Zivarpour, et al.
Published: (2021-03-01)